![logo](/logos/RHT.AX.webp)
Resonance Health Limited
ASX:RHT.AX
0.06 (AUD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Resonance Health Limited |
Symbool | RHT.AX |
Munteenheid | AUD |
Prijs | 0.062 |
Beurswaarde | 27,707,366 |
Dividendpercentage | 0% |
52-weken bereik | 0.047 - 0.088 |
Industrie | Health Information Services |
Sector | Healthcare |
CEO | Mr. Mitchell M. Wells B.Com., B.Comm, L.L.B., LLB |
Website | https://www.resonancehealth.com |
An error occurred while fetching data.
Over Resonance Health Limited
Resonance Health Limited, a healthcare technology and services company, designs, develops, and manufactures software-as-medical devices in the Asia Pacific, North America, South America, Europe, the Middle East, and Africa. It offers FerriScan, a non-invasive MRI based system for quantifying liver iron concentration (LIC); FerriSmart, an artificial intelligence (AI) assisted device
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (AUD)
Cijfers zijn in miljoenen (AUD)